is a member of a class of drugs known as leutinizing hormone-releasing hormone agonists, or LHRH agonists, and has been approved for the treatment of advanced prostate cancer. Eligard works by lowering the levels of testosterone in the body, which may result in a reduction of symptoms related to the disease.